X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
World game at war: why some European nations have threatened a World Cup boycott 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Stem Cells in Drug Discovery & Toxicity Screening 2018" conference has been added to ResearchAndMarkets.com's offering.
Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.
Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda:
- 3D-Cell Culture Based Models
- Technologies in 3D-Cell Culture
- iPSC-derived Cells for Toxicity Testing & Screening
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Development
- Use of Microfluidics Organs-on-Chips for Toxicity Screening
Keynote Speakers
Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University
Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Gary Gintant
Research Fellow, Abbvie
Confirmed Speakers to Date
Ulrich Broeckel
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai
Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi
Research Associate Professor, The University of Missouri
Kennedy Okeyo
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation
Daniele Zink
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
For more information about this conference visit https://www.researchandmarkets.com/research/ndptbs/stem_cells_in?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Drug Abuse Screening, Stem Cells
